FDA Clearance Tracker · P220013-S011
TactiFlex Ablation Catheter, Sensor Enabled
Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 5, 2025
Approved
Time to decision
355 days
Received Mar 15, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P220013-S011
- Device name
- TactiFlex Ablation Catheter, Sensor Enabled
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plymouth, MN
- Received
- Mar 15, 2024
- Decided
- Mar 5, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P220013
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
to add Midwest Sterilization Corporation (Midwest) as an ethylene oxide (EO) sterilization vendor for the TactiFlex Ablation Catheter at the Midwest Jackson, MO facility.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.